moxalactam has been researched along with Female Genital Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daschner, FD; Pelz, K; Petersen, EE; Trennhäuser, M | 1 |
| Aoyama, S; Cho, N; Doi, S; Fujimoto, A; Fukuda, T; Fukunaga, K; Haraguchi, H; Hayashi, S; Hirabayashi, K; Hiraoka, O; Hogaki, M; Ibaragi, K; Jujii, K; Kamigawara, Y; Kamiyoshi, S; Kashiwakura, T; Kobayashi, H; Kondo, I; Kunii, K; Kurasawa, S; Matsuda, S; Matsumoto, Y; Morimoto, N; Motomura, R; Muronosono, E; Nakai, T; Nakamura, H; Nakanishi, K; Ninomiya, K; Okada, E; Oniki, K; Ozawa, M; Risai, T; Saita, K; Sawaragi, I; Seki, K; Shimizu, H; Shimizu, T; Shirafuji, H; Shirakawa, K; Sugimoto, O; Tabei, T; Takase, Z; Tanno, M; Teramoto, C; Watanabe, K; Yamabe, T; Yamada, F; Yamamoto, K; Yuasa, M | 1 |
| Avery, GS; Brogden, RN; Carmine, AA; Heel, RC; Romankiewicz, JA; Speight, TM | 1 |
| Cunningham, FG; DePalma, RT; Hemsell, DL; Kappus, S; Nobles, B; Roark, M | 1 |
| Hogaki, M; Matsumoto, Y; Muronosono, E | 1 |
| Tally, FP | 1 |
| Chimura, T; Hirayama, T; Ogawa, T; Shiina, Y | 1 |
| Gall, SA; Gibbs, RS; Hemsell, DL; Knuppel, RA; Lane, TW; Miller, RD; Newton, ER; Poindexter, AN; Reguero, W; Sweet, RL | 1 |
| Poindexter, AN; Ritter, M; Sweet, R | 1 |
1 review(s) available for moxalactam and Female Genital Diseases
| Article | Year |
|---|---|
Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Topics: Absorption; Adult; Aminoglycosides; Bacteria, Anaerobic; Central Nervous System Diseases; Child; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Female; Genital Diseases, Female; Humans; Infant, Newborn; Inflammation; Kidney Diseases; Kinetics; Male; Moxalactam; Respiratory Tract Infections; Sepsis; Staphylococcus; Streptococcus; Tissue Distribution; Urinary Tract Infections | 1983 |
3 trial(s) available for moxalactam and Female Genital Diseases
| Article | Year |
|---|---|
[Clinical application of 6059-S in the field of obstetrics and gynecology. Effects on gynecological infection and infection of trimester of pregnancy (author's transl)].
Topics: Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Drug Evaluation; Estriol; Female; Fetal Growth Retardation; Genital Diseases, Female; Humans; Middle Aged; Moxalactam; Placental Function Tests; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Progesterone | 1981 |
Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infections.
Topics: Adult; Bacterial Infections; Cefotetan; Cefoxitin; Cephamycins; Clinical Trials as Topic; Female; Genital Diseases, Female; Humans; Moxalactam; Pregnancy; Pregnancy Complications, Infectious; Random Allocation | 1988 |
Cefotetan in the treatment of obstetric and gynecologic infections.
Topics: Adult; Bacterial Infections; Cefotetan; Cefoxitin; Cephamycins; Clinical Trials as Topic; Drug Tolerance; Female; Genital Diseases, Female; Humans; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Pregnancy; Pregnancy Complications, Infectious; Random Allocation | 1986 |
5 other study(ies) available for moxalactam and Female Genital Diseases
| Article | Year |
|---|---|
[Experience with lamoxactam in gynecology: application as a monotherapeutic agent in severe genital infections and determination of its concentration in uterine and tubal tissues].
Topics: Adult; Bacterial Infections; Cephalosporins; Cephamycins; Endometritis; Fallopian Tubes; Female; Genital Diseases, Female; Humans; Middle Aged; Moxalactam; Pelvic Inflammatory Disease; Surgical Wound Infection; Uterus | 1982 |
[Laboratory and clinical studies on latamoxef in the field of obstetrics and gynecology].
Topics: Adult; Aged; Bacterial Infections; Cephalosporins; Cephamycins; Drug Evaluation; Exudates and Transudates; Female; Genital Diseases, Female; Genitalia, Female; Humans; Middle Aged; Moxalactam; Pregnancy | 1983 |
Moxalactam for obstetric and gynecologic infections. In vitro and dose-finding studies.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Bacteroides; Cephalosporins; Cephamycins; Cesarean Section; Drug Evaluation; Enterobacteriaceae; Female; Genital Diseases, Female; Humans; Microbial Sensitivity Tests; Moxalactam; Parametritis; Pelvic Inflammatory Disease; Postoperative Complications | 1981 |
Therapeutic approaches to anaerobic infection.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cefoxitin; Cephamycins; Chloramphenicol; Clindamycin; Drug Combinations; Female; Gastrointestinal Diseases; Genital Diseases, Female; Gram-Negative Anaerobic Bacteria; Humans; Male; Moxalactam; Respiratory Tract Infections; Skin Diseases, Infectious; Suppuration; Ticarcillin | 1981 |
[Effects of prophylactically used latamoxef with tobramycin against postoperative infections on therapeutic drug monitoring and renal function in the field of obstetrics and gynecology].
Topics: Adult; Bacterial Infections; Cesarean Section; Drug Therapy, Combination; Drug Tolerance; Female; Genital Diseases, Female; Humans; Hysterectomy; Infusions, Intravenous; Kidney; Kidney Function Tests; Middle Aged; Moxalactam; Postoperative Complications; Pregnancy; Pregnancy Complications; Premedication; Tobramycin | 1989 |